An intense early flu season, coupled with a pediatric rise in respiratory illnesses, has left families frantically searching for medicines that are in short supply.
Category: Drugs (Pharmaceuticals)
-
FTX’s In-House Performance Coach Is Just as Surprised as You Are
George K. Lerner, a psychiatrist who has worked at the collapsed crypto exchange FTX since last year, said he had no knowledge of wrongdoing at the firm.
-
Walmart Agrees to Pay $3.1 Billion to Settle Opioid Lawsuits Nationwide
The money would help pay for addiction treatment and drug education programs in communities across the United States.
-
Medication Treatment for Addiction Is Shorter for Black and Hispanic Patients, Study Finds
The analysis of 15 years of prescription data showed that the racial disparities are widening.
-
CVS and Walgreens Near $10 Billion Deal to Settle Opioid Cases
The agreement would resolve thousands of lawsuits over the retailers’ role in the addiction crisis. But a large majority of state, local and tribal governments must sign on for it to take effect.
-
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
-
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
-
F.D.A. Confirms Widespread Shortages of Adderall
The agency cited Teva’s continuing supply problems as well as those of other drug makers struggling to fill the gap.